ARENSIA Exploratory Medicine GmbH Email Format
Research ServicesNorth Rhine-westphalia, Germany201-500 Employees
ARENSIA Exploratory Medicine GmbH is a German research services company that operates professional research clinics for early-phase clinical trials, including Phase IB, IIA, and proof-of-concept studies with novel compounds, enrolling a diverse patient population. Headquartered in Düsseldorf, Germany, the company employs between 201 and 500 staff. Its clinics are located within or adjacent to large university or private hospitals and operate in multiple cities across Europe and North America, including Phoenix, Arizona; Bucharest and Cluj-Napoca in Romania; Chisinau in Moldova; Tbilisi in Georgia; Kyiv in Ukraine; and Sofia in Bulgaria. ARENSIA emphasizes faster trial execution and cost efficiency by concentrating operations in a smaller number of clinics, reporting an average 60% reduction in study timelines and about a 50% reduction in budgets for typical Phase IB/IIA proof-of-concept trials. The company highlights strong client retention, with 93% repeat business, and collaborates with leading pharmaceutical companies, biotechs, and CROs, including recent partnerships such as a 2026 agreement with UMF Cluj and a 2025 collaboration with Pasithea Therapeutics.